Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.8800 (14.4%) ($5.3000 - $5.9300) on Wed. Jul. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.72% (three month average) | RSI | 42 | Latest Price | $5.8800(14.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -3.1% a day on average for past five trading days. | Weekly Trend | ANPC declines -10.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(11%) PCY(10%) HYG(9%) LIT(9%) IPO(8%) | Factors Impacting ANPC price | ANPC will decline at least -2.36% in a week (0% probabilities). SHY(-20%) XBI(-8%) IBB(-8%) XLP(-6%) IGOV(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.36% (StdDev 4.72%) | Hourly BBV | 0 () | Intraday Trend | 10.5% | | | |
|
1 - 5 Day Possible Target | $-12.76(-317.01%) | Resistance Level | $6.72 | 5 Day Moving Average | $5.68(3.52%) | 10 Day Moving Average | $6.31(-6.81%) | 20 Day Moving Average | $6.72(-12.5%) | To recent high | -30.7% | To recent low | 15.5% | Market Cap | $50m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |